Filter by
Filter results



All miscellaneous
458 results found
Blog |
26 January 2020

We’re all still waiting, Gilead ...

One year after the pharmaceutical corporation Gilead Sciences promised lower prices for a key drug for people with advanced HIV, why are people still waiting for this lifesaving treatment? Jess Burry, a pharmacist in the Access Campaign, asks if Gilead’s promise is just one big PR stunt.

Press release |

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

MSF calls out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine ...